A new open access publication by our former member Dr. Johannes Krumm is out! Read it here:
High-Throughput Screening and Proteomic Characterization of Compounds Targeting Myeloid-Derived Suppressor Cells
Breaking news! Our latest proteome-wide drug characterization technology 'decryptM' has just gone online at Science!
DecryptM tells you how drugs actually work in cells and it places countless post-translational modification sites into a functional cellular context. We anticipate that decryptM…